EUVIMEDEUVIMED entdecken
LeitlinieOpen Access · CC BY-NC-ND 4.0

Comprehensive characterization and validation of the Prp-hPFN1G118V mouse model: Guidelines for preclinical therapeutic testing for ALS

Kaly A Mueller, Emma G Suneby, Matthew H Ferola, Andy J Moreno, Joshua D Kidd, Kenneth Thompson, Fernando G Vieira, Gregorio Valdez, Theo Hatzipetros

Neurobiology of Disease · 2025

DOI: 10.1016/j.nbd.2025.106975 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Neurobiology of Disease, 2025. Verfasst von Kaly A Mueller und 8 weiteren Autor:innen. Beteiligte Einrichtung: ALS Therapy Development Institute, 480 Arsenal Street, Watertown, MA, USA. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Disease Models, Animal, Profilins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyotrophic Lateral SclerosisDisease Models, AnimalProfilinsAnimalsMiceMice, TransgenicFemaleMaleHumansDrug Evaluation, PreclinicalMotor NeuronsSpinal CordNeuromuscular Junction

Stichwörter der Autor:innen

Amyotrophic lateral sclerosisCMAPMotor neuronsNeurodegenerationNeurofilament light chainNeuroinflammationProfilin1

Substanzen

ProfilinsPFN1 protein, human

Autor:innen und Institutionen

  • ALS Therapy Development Institute, 480 Arsenal Street, Watertown, MA, USA.
  • Department of Molecular Biology, Cell Biology and Biochemistry, Brown University, 70 Ship St, Providence, RI, USA.
  • ALS Therapy Development Institute, 480 Arsenal Street, Watertown, MA, USA. Electronic address: thatzipetros@als.net.

Zitieren

APA

Mueller, K. A., Suneby, E. G., Ferola, M. H., Moreno, A. J., Kidd, J. D., Thompson, K., Vieira, F. G., Valdez, G., & Hatzipetros, T. (2025). Comprehensive characterization and validation of the Prp-hPFN1G118V mouse model: Guidelines for preclinical therapeutic testing for ALS. Neurobiology of Disease. https://doi.org/10.1016/j.nbd.2025.106975

Vancouver

Mueller KA, Suneby EG, Ferola MH, Moreno AJ, Kidd JD, Thompson K, et al. Comprehensive characterization and validation of the Prp-hPFN1G118V mouse model: Guidelines for preclinical therapeutic testing for ALS. Neurobiology of Disease. 2025. doi:10.1016/j.nbd.2025.106975

BibTeX
@article{Mueller2025,
  author = {Mueller, Kaly A and Suneby, Emma G and Ferola, Matthew H and Moreno, Andy J and Kidd, Joshua D and Thompson, Kenneth and Vieira, Fernando G and Valdez, Gregorio and Hatzipetros, Theo},
  title = {Comprehensive characterization and validation of the Prp-hPFN1G118V mouse model: Guidelines for preclinical therapeutic testing for ALS},
  journal = {Neurobiology of Disease},
  year = {2025},
  doi = {10.1016/j.nbd.2025.106975}
}
Kostenlos starten →